يعرض 1 - 10 نتائج من 35 نتيجة بحث عن '"Donica, Margarita"', وقت الاستعلام: 1.03s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: de Vries , E G E , Rüschoff , J , Lolkema , M , Tabernero , J , Gianni , L , Voest , E , de Groot , D J A , Castellano , D , Erb , G , Naab , J , Donica , M , Deurloo , R , van der Heijden , M S & Viale , G 2023 , ' Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma ' , Cancer Medicine , vol. 12 , no. 11 , pp. 12071-12083 . ....

    وصف الملف: application/pdf

  2. 2
    دورية أكاديمية

    المساهمون: Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU), Royal Brompton Hospital, Université Paris Diderot - Paris 7 (UPD7), University Health Network Toronto, ON, Canada, University of Toronto, IRCCS Ospedale San Raffaele Milan, Italy, Humanitas University Milan (Hunimed), Clinic Barcelona Hospital Universitari, Universitat de Barcelona (UB), F. Hoffmann-La Roche Basel, Baylor College of Medicine (BCM), Baylor University

    المصدر: The Journal of Allergy and Clinical Immunology: In Practice ; https://ut3-toulouseinp.hal.science/hal-03669233Test ; The Journal of Allergy and Clinical Immunology: In Practice, 2020, 8 (8), pp.2630-2639.e6. ⟨10.1016/j.jaip.2020.03.038⟩

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32304841; hal-03669233; https://ut3-toulouseinp.hal.science/hal-03669233Test; https://ut3-toulouseinp.hal.science/hal-03669233/documentTest; https://ut3-toulouseinp.hal.science/hal-03669233/file/Buhl_2020.pdfTest; PUBMED: 32304841; WOS: 000577891000026

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المصدر: Gridelli , C , Carpeno , J , Dingemans , A-M C , Griesinger , F , Grossi , F , Langer , C , Ohe , Y , Syrigos , K , Thatcher , N , Das-Gupta , A , Truman , M , Donica , M , Smoljanovic , V & Bennouna , J 2018 , ' Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer The AvaALL Randomized Clinical Trial ' , JAMA Oncology , vol. 4 , no. 12 , 183486 . https://doi.org/10.1001/jamaoncol.2018.3486Test

    مصطلحات موضوعية: 1ST-LINE TREATMENT, OPEN-LABEL, CHEMOTHERAPY

  7. 7
    دورية أكاديمية

    المساهمون: Hospital Universitario La Paz, Istituto Clinico Humanitas Milan (IRCCS Milan), Humanitas University Milan (Hunimed), Università degli Studi di Milano-Bicocca = University of Milano-Bicocca (UNIMIB), University College London Hospitals (UCLH), Universidade Federal de Minas Gerais = Federal University of Minas Gerais Belo Horizonte, Brazil (UFMG), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Service de recherche clinique Centre François Baclesse, Centre Régional de Lutte contre le Cancer François Baclesse Caen (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), University of Craiova, University of the Witwatersrand Johannesburg (WITS), Universidade de São Paulo Medical School (FMUSP), F. Hoffmann-La Roche Basel, Clínica Universidad de Navarra Pamplona

    المصدر: ISSN: 0090-8258.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32763109; hal-03668904; https://ut3-toulouseinp.hal.science/hal-03668904Test; PUBMED: 32763109; WOS: 000576604900002

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المصدر: Journal of Biopharmaceutical Statistics ; volume 25, issue 5, page 1020-1038 ; ISSN 1054-3406 1520-5711

  10. 10
    دورية أكاديمية

    المؤلفون: Götte, Heiko1 (AUTHOR) heiko.goette@merckgroup.com, Donica, Margarita2 (AUTHOR), Mordenti, Giacomo3 (AUTHOR)

    المصدر: Journal of Biopharmaceutical Statistics. 2015, Vol. 25 Issue 5, p1020-1038. 19p. 6 Charts, 2 Graphs.